Novo Holdings picks up injectables CDMO in push for single-use manufacturing tech

For 25 years, Ritedose has been a CDMO that’s provided sterile, aseptic production of single-dose medication for more than 8 billion doses. Novo Holdings has taken notice, acquiring the Columbia, GA-based company from AGIC Capital and Humanwell.